Status: current, Defined. Date: 31-Oct 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4753621000168119 | Bevaciptin (bevacizumab 400 mg / 16 mL) injection, 16 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4753631000168116 | Bevaciptin 400 mg/16 mL injection, 16 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bevaciptin 400 mg/16 mL injection, 16 mL vial | Is a | Bevaciptin | true | Inferred relationship | Some | ||
| Bevaciptin 400 mg/16 mL injection, 16 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Bevaciptin 400 mg/16 mL injection, 16 mL vial | Is a | bevacizumab 400 mg/16 mL injection, vial | true | Inferred relationship | Some | ||
| Bevaciptin 400 mg/16 mL injection, 16 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Bevaciptin 400 mg/16 mL injection, 16 mL vial | has Australian BoSS | bevacizumab | true | Inferred relationship | Some | 1083981768 | |
| Bevaciptin 400 mg/16 mL injection, 16 mL vial | has intended active ingredient | bevacizumab | true | Inferred relationship | Some | 1083981768 | |
| Bevaciptin 400 mg/16 mL injection, 16 mL vial | has unit of use | vial | true | Inferred relationship | Some | 641494356 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bevaciptin 400 mg/16 mL injection, 16 mL vial | has TPUU | True | Bevaciptin 400 mg/16 mL injection, 16 mL vial | Inferred relationship | Some | 1582348 |
| Bevaciptin 400 mg/16 mL injection, 16 mL vial | has TPUU | True | Bevaciptin 400 mg/16 mL injection, 16 mL vial | Inferred relationship | Some | 503528888 |
Reference Sets
Trade product unit of use reference set
FHIR